Verified employee & interview reviews

Flipkart Health+ Reviews

Bengaluru, Karnataka

4.3/ 5

3 reviews

Flipkart Health+ operates under the legal name Flipkart Health Limited and functions as a prominent digital healthcare marketplace and online pharmacy platform in India. Initially incorporated in July 2011 as Sasta Sundar Shop Private Limited and later known as Sastasundar Marketplace Limited, the company underwent a major transformation in November 2021. During this time, the homegrown consumer internet ecosystem leader, the Flipkart Group, which is backed by Walmart, acquired a majority stake in the Kolkata-based health-tech startup. This acquisition marked Flipkart's strategic foray into the rapidly expanding Indian healthcare sector, leading to the official launch of the Flipkart Health+ application in April 2022. The corporate headquarters and registered office of Flipkart Health Limited are situated at DLF IT Park in Rajarhat, New Town, Kolkata, West Bengal, while the brand heavily integrates with Flipkart's primary technological and corporate frameworks based in Bengaluru. The company's leadership has featured notable corporate executives, including Ajay Veer Yadav, the Senior Vice President who oversaw the vertical, and Prashant Jhaveri, who served as the Chief Executive Officer until mid-2023. The registered board of directors includes Yogesh Gupta, Bankim Chandra Shah, and Nitesh Agarwal, building on the foundational work of original founders such as Pranesh Gupta, Pritam Ghosh, and Sushil Kumar Khaitan. As an e-commerce platform dedicated to wellness, Flipkart Health+ was designed to provide multi-channel access to affordable and genuine pharmaceutical products, over-the-counter medications, homeopathy and ayurvedic treatments, medical devices, and personal healthcare items. By capitalizing on the expansive logistics network of eKart, Flipkart’s internal supply chain arm, the platform targeted a pan-India reach covering over twenty thousand pincodes. The operational framework aimed to expand beyond medicine delivery to incorporate digital diagnostics and telehealth consultations, directly competing with established industry players like PharmEasy, Netmeds, and Tata 1mg. Financially, the company is classified as an unlisted public limited Indian non-government company limited by shares. According to corporate filings, Flipkart Health Limited possesses an authorized share capital of fifteen point fifty-six crore rupees and a paid-up capital of approximately eighty-four point seventy-seven lakh rupees. For the fiscal periods trailing up to 2025, the company reported operating revenues within the range of twenty-five to fifty crore rupees. Within eighteen months of its national launch, the platform achieved significant market penetration, capturing a seventeen percent market share to become the third most popular e-pharmacy app in India. However, strategic corporate shifts led to the conclusion of the partnership with SastaSundar in January 2025, resulting in the winding down of the Flipkart Health+ branded app operations and the return of the core brand identity back to Sasta Sundar.